Medclair AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	56.07	35.95	42.42	28.17	13.32
Revenue Growth (YoY)	55.96%	-15.25%	50.60%	111.49%	107.70%
Cost of Revenue	18.02	12.6	17.66	7.76	5.8
Gross Profit	38.04	23.35	24.76	20.41	7.52
Selling, General & Admin	27.39	24.31	21.91	19	15.32
Other Operating Expenses	-0.05	-0.08	-0.05	-	-0.09
Operating Expenses	32.34	29.51	27.39	24.38	20.34
Operating Income	5.7	-6.17	-2.63	-3.97	-12.82
Interest Expense	-0.59	-0.23	-0.37	-0.08	-0.11
Interest & Investment Income	0.1	0.19	0.2	-	-
Currency Exchange Gain (Loss)	-1.03	-0.57	-0.83	-0.37	-0.09
Other Non Operating Income (Expenses)	-	-	-0	-	-
EBT Excluding Unusual Items	4.19	-6.76	-3.63	-4.42	-13.01
Gain (Loss) on Sale of Assets	0.47	6.1	0.85	-0.57	-
Pretax Income	4.65	-0.66	-2.78	-4.99	-13.01
Income Tax Expense	-	-	0.01	0.01	0.01
Net Income	4.65	-0.66	-2.79	-5	-13.02
Net Income to Common	4.65	-0.66	-2.79	-5	-13.02
Shares Outstanding (Basic)	78	66	93	83	81
Shares Outstanding (Diluted)	78	66	93	83	81
Shares Change (YoY)	16.79%	-28.47%	11.40%	2.41%	-
EPS (Basic)	0.06	-0.01	-0.03	-0.06	-0.16
EPS (Diluted)	0.06	-0.01	-0.03	-0.06	-0.16
Free Cash Flow	6.91	1.19	4.23	-11.77	-8.68
Free Cash Flow Per Share	0.09	0.02	0.05	-0.14	-0.11
Gross Margin	67.85%	64.94%	58.38%	72.46%	56.45%
Operating Margin	10.17%	-17.16%	-6.20%	-14.09%	-96.25%
Profit Margin	8.30%	-1.85%	-6.57%	-17.75%	-97.76%
Free Cash Flow Margin	12.32%	3.31%	9.97%	-41.79%	-65.16%
EBITDA	10.41	-1.49	1.88	0.12	-8.85
EBITDA Margin	18.57%	-4.16%	4.44%	0.41%	-66.44%
D&A For EBITDA	4.71	4.67	4.52	4.09	3.97
EBIT	5.7	-6.17	-2.63	-3.97	-12.82
EBIT Margin	10.17%	-17.16%	-6.20%	-14.09%	-96.25%
Revenue as Reported	56.58	36.71	43.32	28.44	13.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.